Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR
ConditionBrain Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorStanford University
About this trial
The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of human brains. The study will also allow us to compare the imaging performance of the investigator's brain-dedicated PET insert against a commercial whole-body permanently integrated PET/MRI system using a common radiopharmaceutical.
Eligibility criteria
Qualifiers
Whole body radiation dose within the last year of less than 5000 mrem
Subjects intended for injected tracer studies (not associated with another study) must be willing/able to undergo injection of 6-12 mCi of either FDG or Neuraceq radiotracer. Both tracers are FDA approved
Subjects will be at least 21 years of age
Subject provides written informed consent
Disqualifiers
For patients who will be receiving a tracer injection, no known allergy to the imaging agents
Participant has a history of or current diagnosis of cancer
Participant is pregnant or nursing
Metallic implants (contraindicated for MRI)
Trial design
Treatments tested in this trial
- Injected radiotracer with PET Insert
- Pre-injected group with PET insert
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov